Eur J Endocrinol
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


DOI: 10.1530/eje.0.1310385
European Journal of Endocrinology, Vol 131, Issue 4, 385-390
Copyright © 1994 by European Society of Endocrinology
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kimura, T.
Right arrow Articles by Tanizawa, O.
Right arrow Search for Related Content
PubMed
Right arrow Articles by Kimura, T.
Right arrow Articles by Tanizawa, O.

Molecular characterization of a cloned human oxytocin receptor

Tadashi Kimura, Yoko Makino, Fumitaka Saji, Masahiko Takemura, Tomoko Inoue, Tomoyuki Kikuchi, Yasue Kubota, Chihiro Azuma, Toshikatsu Nobunaga, Yoshihiro Tokugawa and Osamu Tanizawa

Kimura T, Makino Y, Saji F, Takemura M, Inoue T, Kikuchi T, Kubota Y, Azuma C, Nobunaga T, Tokugawa Y, Tanizawa O. Molecular characterization of a cloned human oxytocin receptor. Eur J Endocrinol 1994;131:385–90. ISSN 0804–4643

We describe here the binding and functional properties of a cloned human oxytocin receptor (OTR). We established a transient OTR expression system on COS-1 cells, which do not express vasopressin receptors. With the transfected cells and [3H]oxytocin, the dissociation constant (Kd) of OTR to oxytocin was 6.0 ±1.1 nmol/l; the binding properties of several oxytocin-related peptides were also examined. The functional properties of OTR were determined by an electrophysiological method, using a Xenopus laevis oocyte injected with in vitro transcribed OTR mRNA. These two methods showed that [Phe2,Orn8]vasotocin, a vasopressin agonist, was an OTR antagonist. A combination of these methods using cloned OTR cDNA is a novel and effective method for the investigation of oxytocin-related ligands.

Tadashi Kimura, Department of Obstetrics and Gynecology, Osaka University Medical School, 2-2 Yamadaoka, Suita City, Osaka 565, Japan




This article has been cited by other articles:


Home page
Am. J. Physiol. Endocrinol. Metab.Home page
M. Zhong, B. Parish, D. A. Murtazina, C.-Y. Ku, and B. M. Sanborn
Amino acids in the COOH-terminal region of the oxytocin receptor third intracellular domain are important for receptor function
Am J Physiol Endocrinol Metab, April 1, 2007; 292(4): E977 - E984.
[Abstract] [Full Text] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
Y. Takayanagi, M. Yoshida, I. F. Bielsky, H. E. Ross, M. Kawamata, T. Onaka, T. Yanagisawa, T. Kimura, M. M. Matzuk, L. J. Young, et al.
Pervasive social deficits, but normal parturition, in oxytocin receptor-deficient mice
PNAS, November 1, 2005; 102(44): 16096 - 16101.
[Abstract] [Full Text] [PDF]


Home page
EndocrinologyHome page
B. Schmid, S. Wong, and B. F. Mitchell
Transcriptional Regulation of Oxytocin Receptor by Interleukin-1{beta} and Interleukin-6
Endocrinology, April 1, 2001; 142(4): 1380 - 1385.
[Abstract] [Full Text]


Home page
Physiol. Rev.Home page
G. Gimpl and F. Fahrenholz
The Oxytocin Receptor System: Structure, Function, and Regulation
Physiol Rev, April 1, 2001; 81(2): 629 - 683.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
R. Postina, E. Kojro, and F. Fahrenholz
Separate Agonist and Peptide Antagonist Binding Sites of the Oxytocin Receptor Defined by Their Transfer into the V2 Vasopressin Receptor
J. Biol. Chem., December 6, 1996; 271(49): 31593 - 31601.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Copyright © 1994 European Society of Endocrinology.